These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36180278)

  • 1. Pathophysiology of Chronic Bronchial Infection in Bronchiectasis.
    Solarat B; Perea L; Faner R; de La Rosa D; Martínez-García MÁ; Sibila O
    Arch Bronconeumol; 2023 Feb; 59(2):101-108. PubMed ID: 36180278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
    [No Abstract]   [Full Text] [Related]  

  • 3. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis.
    Sibila O; Suarez-Cuartin G; Rodrigo-Troyano A; Fardon TC; Finch S; Mateus EF; Garcia-Bellmunt L; Castillo D; Vidal S; Sanchez-Reus F; Restrepo MI; Chalmers JD
    Respirology; 2015 Oct; 20(7):1082-8. PubMed ID: 26172851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway microbiology and host defences in paediatric non-CF bronchiectasis.
    Grimwood K
    Paediatr Respir Rev; 2011 Jun; 12(2):111-8. PubMed ID: 21458739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic bronchial infection: the problem of Pseudomonas aeruginosa].
    Cantón R; Fernández Olmos A; de la Pedrosa EG; del Campo R; Antonia Meseguer M
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():8-13. PubMed ID: 21703473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study.
    Duan JL; Li CY; Jiang Y; Liu C; Huang PR; Gao LF; Guan WJ; Cheng LL
    Respir Res; 2024 Jul; 25(1):283. PubMed ID: 39020401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.
    Kapur N; Grimwood K; Masters IB; Morris PS; Chang AB
    Pediatr Pulmonol; 2012 Mar; 47(3):300-7. PubMed ID: 21901858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchiectasis.
    Barbosa M; Chalmers JD
    Presse Med; 2023 Sep; 52(3):104174. PubMed ID: 37778637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungi in Bronchiectasis: A Concise Review.
    Máiz L; Nieto R; Cantón R; Gómez G de la Pedrosa E; Martinez-García MÁ
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of Bronchiectasis.
    Keir HR; Chalmers JD
    Semin Respir Crit Care Med; 2021 Aug; 42(4):499-512. PubMed ID: 34261175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review.
    Inchingolo R; Pierandrei C; Montemurro G; Smargiassi A; Lohmeyer FM; Rizzi A
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33804631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
    Venning V; Bartlett J; Jayaram L
    Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory pathogens in patients with acute exacerbation of non-cystic fibrosis bronchiectasis from a developing country.
    Shahid S; Jabeen K; Iqbal N; Farooqi J; Irfan M
    Monaldi Arch Chest Dis; 2021 Apr; 91(2):. PubMed ID: 33904293
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Vidaillac C; Chotirmall SH
    Expert Rev Respir Med; 2021 May; 15(5):649-662. PubMed ID: 33736539
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic obstructive pulmonary disease and bronchial colonization/infection].
    Fournier M
    Presse Med; 2001 Oct; 30(31 Pt 2):11-5. PubMed ID: 11721485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung microbiome: new insights into bronchiectasis' outcome.
    Azoicai A; Lupu A; Alexoae MM; Starcea IM; Mocanu A; Lupu VV; Mitrofan EC; Nedelcu AH; Tepordei RT; Munteanu D; Mitrofan C; Salaru DL; Ioniuc I
    Front Cell Infect Microbiol; 2024; 14():1405399. PubMed ID: 38895737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial treatment of non-cystic fibrosis bronchiectasis.
    Grimwood K; Bell SC; Chang AB
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1277-96. PubMed ID: 25156239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease.
    Di Pasquale M; Aliberti S; Mantero M; Gramegna A; Blasi F
    Expert Opin Pharmacother; 2020 Nov; 21(16):1975-1990. PubMed ID: 32808825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.